ロード中...
Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany
Objective: To compare the treatment costs of insulin glargine (IG; Lantus(®)) to detemir (ID; Levemir(®)), both combined with bolus insulin aspart (NovoRapid(®)) in type 2 diabetes (T2D) in Germany. Methods: Cost comparison was based on data of a 1-year randomised controlled trial [1]. IG was admini...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
German Medical Science GMS Publishing House
2010
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2921814/ https://ncbi.nlm.nih.gov/pubmed/20725588 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3205/000106 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|